Biolife Solutions (BLFS) Cash & Current Investments (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash & Current Investments data on file, last reported at $81.0 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments fell 8.56% year-over-year to $81.0 million in Q1 2026; TTM through Mar 2026 was $81.0 million, a 8.56% decrease from a year earlier, with the FY2025 full-year figure at $88.9 million, down 11.72% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $81.0 million, down from $88.9 million in the prior quarter.
• Over the last five years, Cash & Current Investments for BLFS reached as high as $100.7 million in Q4 2024 and fell as low as $19.5 million in Q4 2022.
• Historically, Cash & Current Investments has averaged $57.9 million across 5 years, with a median of $54.9 million in 2023.
• Across the five-year window, Cash & Current Investments tumbled 72.13% in 2022 and surged 270.9% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $19.5 million in 2022, then soared by 126.9% to $44.2 million in 2023, then soared by 127.99% to $100.7 million in 2024, then slipped by 11.72% to $88.9 million in 2025, then retreated by 8.92% to $81.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $81.0 million in Q1 2026, $88.9 million in Q4 2025, and $79.0 million in Q3 2025.